바이오의약품 수탁제조 시장 : 시장 규모, 점유율, 성장 분석 - 서비스별, 유형별, 운용 규모별, 원료별, 분자 유형별, 지역별 업계 예측(2026-2033년)

Global Biopharmaceuticals Contract Manufacturing Market size was valued at USD 17.85 Billion in 2024 and is poised to grow from USD 19.32 Billion in 2025 to USD 36.29 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).

The global biopharmaceutical contract manufacturing market is poised for significant growth due to reduced investment for new drug development, access to advanced technologies, increased flexibility, and expedited market entry for innovative products. The establishment of new manufacturing facilities enhances production capacity to meet the rising consumer demand. Technological advancements and innovative bioprocessing methods are key drivers, enabling contract service providers to address manufacturing challenges such as high production costs and efficiency during batch transitions. Additionally, strategic acquisitions, mergers, and collaborations among prominent market players are fostering increased demand for contract manufacturing services worldwide, reinforcing market growth and expanding capabilities within the biopharmaceutical sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Contract Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopharmaceuticals Contract Manufacturing Market Segments Analysis

Global Biopharmaceuticals Contract Manufacturing Market is segmented by Service, Type, Scale Of Operation, Source, Molecule Type,TherapeuticArea and region. Based on Service, the market is segmented into Manufacturing, Formulation & Fill-Finish, Packaging & Labeling and Other Services. Based on Type, the market is segmented into Biologic Drug Substance Manufacturing and Biologic Drug Product Manufacturing. Based on Scale Of Operation, the market is segmented into Commercial Operations and Clinical Operations. Based on Source, the market is segmented into Mammalian Expression Systems and Non-Mammalian Expression Systems. Based on Molecule Type, the market is segmented into Monoclonal Antibodies, Cell & Gene Therapies, Antibody-Drug Conjugates, Vaccines, Therapeutic Peptides & Proteins and Other Molecule Types. Based on Therapeutic Area, the market is segmented into Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases and Other Therapeutic Areas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopharmaceuticals Contract Manufacturing Market

The global biopharmaceuticals contract manufacturing market is poised for growth due to several key drivers, including the persistent increase in demand for generics and escalating research and development activities. A surge in investments focused on advanced technologies also contributes to market expansion. Additionally, the rising need for biological therapies, coupled with advancements in the nuclear medicine sector, is expected to further enhance market dynamics. The growing emphasis on specialty medicines serves to solidify this upward trajectory, positioning the global biopharmaceuticals landscape for robust development and innovation, which will likely transform the market in the foreseeable future.

Restraints in the Global Biopharmaceuticals Contract Manufacturing Market

The global biopharmaceuticals contract manufacturing market faces several challenges that may hinder its growth. Key issues related to the manufacturing process, including labeling inconsistencies, packaging complications, and difficulties in sterilization, are significant obstacles. Furthermore, a lack of consumer trust and limited knowledge regarding the manufacturing processes could also impede the market's expansion. These factors contribute to an environment that may deter potential investments and partnerships within the industry, ultimately affecting the overall development and success of biopharmaceutical contract manufacturing. Stakeholders must address these concerns to foster a more favorable growth landscape and enhance market confidence.

Market Trends of the Global Biopharmaceuticals Contract Manufacturing Market

The global biopharmaceuticals contract manufacturing market is witnessing a robust upward trend fueled by advancements in technology and increased scientific exploration. The growing integration of artificial intelligence (AI) within the manufacturing landscape is enhancing operational efficiencies, allowing for more accurate analysis of complex biological processes and patient data. This technological shift not only streamlines production cycles but also facilitates personalized medicine approaches, catering to a diverse range of therapeutic needs. As stakeholders increasingly recognize the potential of AI-driven innovations in optimizing drug development and manufacturing processes, the market is poised for significant growth, driven by rising demand for effective biopharmaceutical solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies
• FDA Approved Biopharmaceuticals CMOs Centers

Global Biopharmaceuticals Contract Manufacturing Market Size by Service & CAGR (2026-2033)

• Market Overview
• Manufacturing
• Formulation & Fill-Finish
• Packaging & Labeling
• Other Services

Global Biopharmaceuticals Contract Manufacturing Market Size by Type & CAGR (2026-2033)

• Market Overview
• Biologic Drug Substance Manufacturing
• Biologic Drug Product Manufacturing

Global Biopharmaceuticals Contract Manufacturing Market Size by Scale Of Operation & CAGR (2026-2033)

• Market Overview
• Commercial Operations
• Clinical Operations

Global Biopharmaceuticals Contract Manufacturing Market Size by Source & CAGR (2026-2033)

• Market Overview
• Mammalian Expression Systems
• Non-Mammalian Expression Systems

Global Biopharmaceuticals Contract Manufacturing Market Size by Molecule Type & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies
• Cell & Gene Therapies
• Antibody-Drug Conjugates
• Vaccines
• Therapeutic Peptides & Proteins
• Other Molecule Types

Global Biopharmaceuticals Contract Manufacturing Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncology
• Autoimmune Diseases
• Metabolic Diseases
• Cardiovascular Diseases
• Neurology
• Infectious Diseases
• Other Therapeutic Areas

Global Biopharmaceuticals Contract Manufacturing Market Size & CAGR (2026-2033)

• North America (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
  • US
  • Canada
• Europe (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi Biologics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AGC Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JSR Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stelis (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Fosun Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lotte Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hepalink Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Curia Global, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations